Terms: = Head and neck cancer AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C AND Treatment
26 results:
1. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid cancer Survivors in the United States.
Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
[No Abstract] [Full Text] [Related]
2. Nutritional status in patients with hepatocellular carcinoma: Potential relevance for clinical outcome.
van Dijk AM; Coppens BJP; van Beers MA; Bruins Slot AS; Verstraete CJR; de Bruijne J; Vleggaar FP; van Erpecum KJ
Eur J Intern Med; 2022 Oct; 104():80-88. PubMed ID: 35902333
[TBL] [Abstract] [Full Text] [Related]
3. Impact of histology classification on pathologic treatment response and overall survival in distal esophageal cancer patients: a propensity matched analysis.
Saeed SM; Naffouje S; Mehta R; Hoffe SE; Fontaine JP; Lauwers GY; Shah P; Frakes J; Pimiento JM
Dis Esophagus; 2021 Aug; 34(8):. PubMed ID: 32996568
[TBL] [Abstract] [Full Text] [Related]
4. Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial.
Barbour AP; Walpole ET; Mai GT; Barnes EH; Watson DI; Ackland SP; Martin JM; Burge M; Finch R; Karapetis CS; Shannon J; Nott LM; Varma S; Marx G; Falk GL; Gebski V; Oostendorp M; Wilson K; Thomas J; Lampe G; Zalcberg JR; Simes J; Smithers BM;
Ann Oncol; 2020 Feb; 31(2):236-245. PubMed ID: 31959340
[TBL] [Abstract] [Full Text] [Related]
5. Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (cdkn2c) loss assay in sporadic medullary thyroid carcinoma.
Maxwell JE; Gule-Monroe MK; Subbiah V; Hu M; Perrier ND; Cabanillas ME; Lee JE; Graham PH; Cote GJ; Busaidy NL; Grubbs EG
Surgery; 2020 Jan; 167(1):80-86. PubMed ID: 31648931
[TBL] [Abstract] [Full Text] [Related]
6. Laryngeal Synovial Sarcoma: A Systematic Review of the Last 40 Years of Reported Cases.
Shein G; Sandhu G; Potter A; Loo C; Jacobson I; Anazodo A
Ear Nose Throat J; 2021 Feb; 100(2):NP93-NP104. PubMed ID: 31309846
[TBL] [Abstract] [Full Text] [Related]
7. Parathyroid Carcinoma.
Cetani F; Pardi E; Marcocci C
Front Horm Res; 2019; 51():63-76. PubMed ID: 30641523
[TBL] [Abstract] [Full Text] [Related]
8. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional treatment Options.
Gay LM; Kim S; Fedorchak K; Kundranda M; Odia Y; Nangia C; Battiste J; Colon-Otero G; Powell S; Russell J; Elvin JA; Vergilio JA; Suh J; Ali SM; Stephens PJ; Miller VA; Ross JS
Oncologist; 2017 Jul; 22(7):834-842. PubMed ID: 28495808
[TBL] [Abstract] [Full Text] [Related]
10. [Clinical analysis of laryngeal non-Hodgkin's lymphoma].
Chen L; Zhang M; Li C; Zhou L; Zhu JX; Pang SY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(7):546-548. PubMed ID: 29871307
[No Abstract] [Full Text] [Related]
11. Can Epstein-Barr virus DNA load in nasopharyngeal brushings or whole blood predict recurrent nasopharyngeal carcinoma in a non-endemic region? A prospective nationwide study of the Dutch head and neck Oncology Cooperative Group.
Stoker SD; Wildeman MA; Novalic Z; Fles R; van der Noort V; de Bree R; Braunius WW; van den Broek GB; Kreike B; Kross KW; Juwana H; Ramayanti O; Verkuijlen SA; de Boer JP; Greijer AE; Middeldorp JM; Tan IB
Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1557-67. PubMed ID: 25929413
[TBL] [Abstract] [Full Text] [Related]
12. Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target.
Demeure MJ; Aziz M; Rosenberg R; Gurley SD; Bussey KJ; Carpten JD
World J Surg; 2014 Jun; 38(6):1296-305. PubMed ID: 24633422
[TBL] [Abstract] [Full Text] [Related]
13. TNF-α promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx.
Zhang C; Sturgis EM; Zheng H; Zafereo ME; Wei Q; Li G
Int J Cancer; 2014 Oct; 135(7):1615-24. PubMed ID: 24550071
[TBL] [Abstract] [Full Text] [Related]
14. Cell cycle deregulation and TP53 and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas.
Pita JM; Figueiredo IF; Moura MM; Leite V; Cavaco BM
J Clin Endocrinol Metab; 2014 Mar; 99(3):E497-507. PubMed ID: 24423316
[TBL] [Abstract] [Full Text] [Related]
15. Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.
Sikka A; Kaur M; Agarwal C; Deep G; Agarwal R
Cell Cycle; 2012 Apr; 11(7):1374-82. PubMed ID: 22421144
[TBL] [Abstract] [Full Text] [Related]
16. Long-term health-related quality of life for disease-free esophageal cancer patients.
Donohoe CL; McGillycuddy E; Reynolds JV
World J Surg; 2011 Aug; 35(8):1853-60. PubMed ID: 21553202
[TBL] [Abstract] [Full Text] [Related]
17. Medullary thyroid carcinoma: long-term outcomes of surgical treatment.
Abraham DT; Low TH; Messina M; Jackson N; Gill A; Chou AS; Delbridge L; Learoyd D; Robinson BG; Sidhu S; Sywak M
Ann Surg Oncol; 2011 Jan; 18(1):219-25. PubMed ID: 20878247
[TBL] [Abstract] [Full Text] [Related]
18. Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers detected by xMAP technology.
Gu AD; Lu LX; Xie YB; Chen LZ; Feng QS; Kang T; Jia WH; Zeng YX
J Transl Med; 2009 Aug; 7():73. PubMed ID: 19698162
[TBL] [Abstract] [Full Text] [Related]
19. Dynamic delivery of IMRT using an independent collimator: a model study.
Zhang Y; Hu Y; Ma L; Dai J
Phys Med Biol; 2009 Apr; 54(8):2527-39. PubMed ID: 19336843
[TBL] [Abstract] [Full Text] [Related]
20. Epstein-Barr virus (EBV) serology for predicting distant metastases in a white juvenile patient with nasopharyngeal carcinoma and no clinical response to EBV lytic induction therapy.
Stevens SJ; Zwaan CM; Verkuijlen SA; Middeldorp JM
Head Neck; 2006 Nov; 28(11):1040-5. PubMed ID: 16933315
[TBL] [Abstract] [Full Text] [Related]
[Next]
